In comparison with myeloma cells, SCs from MM patients overexpress DKK-1 binding receptors LRP5/6 and Krm1/2, which probably lead to the blockade of intracellular Wnt signaling in SCs. This evidence concerns the gene DKK1 and plasma cell myeloma.